Back

Economic burden of elevated lipoprotein(a) in secondary prevention atherosclerotic cardiovascular disease cohort from England

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Public health and cardiovascular disease Health Economics ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mrs Maria Caido

London (United Kingdom of Great Britain & Northern Ireland)

12 More presentations in this session

Presentation thumbnail
Discussant - Public health and cardiovascular disease
Presentation thumbnail
A value-based analysis of the systematic use of dapagliflozin in patients with heart failure
Professor H. Bueno (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Chronic disease trajectory network and Monte Carlo simulation in Chinese population
Doctor J. Fei (Beijing, CN)
Abstract
Presentation thumbnail
Multiscale entropy, a novel non-linear method, better reflected the detrimental impact of ambient air pollution on 24-hour heart rate variability than linear method or detrended fluctuation analysis
Doctor C. Huang (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
The first year of generic NOACs: implications for patients and the healthcare system
Doctor R. Barbosa Sousa (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Public health and cardiovascular disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Association of elevated lipoprotein(a) with future major adverse cardiovascular events in recurrent ASCVD patients: analysis of a large US electronic health record database
thumbnail
Congress Presentation
Impact of lipoprotein(a) concentrations on atherosclerotic cardiovascular disease onset: a survival analysis
thumbnail
Congress Presentation
Ethnic differences in lipoprotein(a)-associated ASCVD risk and the impact of standard modifiable cardiovascular risk factors: insights from the multi-ethnic HELIUS cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources